Eli Lilly is officially the first pharma to add pricing information to a TV commercial. The move—initially for Trulicity in a spot that debuted this week—will expand to its other TV-promoted drugs by ...
FDA chides Eli Lilly for 2nd misleading ad in 2 months, this time for diabetes blockbuster Trulicity
After neatly wrapping up concerns over a series of Emgality ads last month, Eli Lilly is back in hot water with the FDA's Office of Prescription Drug Promotion. The FDA gave Lilly a slap on the wrist ...
Novo Nordisk is going all in on Ozempic, its once-weekly GLP-1 injection for diabetes that was approved by the FDA in December 2017. The Danish pharma has shifted marketing spend away from Victoza, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback